Criminal justice treatment admissions for methamphetamine use in california: A focus on proposition 36

Journal of Psychoactive Drugs

Volumn 39, Issue , 2007, Pages 367-381

  Anglin, M Douglas ^a   Urada, Darren ^a   Brecht, Mary Lynn ^a   Hawken, Angela ^a   Rawson, Richard ^a   Longshore, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug abuse; Methamphetamine; Offender drug treatment; Proposition 36; SACPA; Substance abuse

Indexed keywords

CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ADULT; ARTICLE; CRIMINAL LAW; DRUG ABUSE; FACTUAL DATABASE; FEMALE; HUMAN; MALE; REGRESSION ANALYSIS; STATISTICS; TREATMENT OUTCOME; UNITED STATES; ACT; CONFERENCE PAPER; CRIMINAL JUSTICE; DEMOGRAPHY; DRUG DEPENDENCE; LAW ENFORCEMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OFFENDER; POLICY; PSYCHIATRIC TREATMENT; REHABILITATION CENTER; SUBSTANCE ABUSE;

ADULT; AMPHETAMINE-RELATED DISORDERS; CALIFORNIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CRIMINAL LAW; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; METHAMPHETAMINE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 38348999470     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2007.10399898     Document Type: Article

References (88)

1. Anglin, M.D. & Perrochet, B. 1998. Drug use and crime: A historical review of research conducted by the UCLA Integrated Substance Abuse Programs. Substanc e Use and Misuse33 (9): 1871-1914.
2. Associated Press. 2003. As meth use jumps, so does children's risk. Los Angeles Times January 20: A6.
3. Baker, A.; Boggs, T. & Lewin, T. 2001. Randomized controlled trial of brief cognitive-behavioral interventions among regular users of amphetamine. Addiction96: 1279-87.
4. Belenko, S. 1998. Research on drug courts: A critical review. National Drug Court Institute Review1: 1-42.
5. Benda, B. 2002. Factors associated with rehospitalization among veterans in a substance abuse treatment program. Psychiatric Services53: 1176-78.
6. Brecht, M.-L.; Greenwell, L & von Mayrhauser, C. 2006. Outcomes of treatment for methamphetamine use. Journal of Psychoactive Drugs SARC Supplement 3: 415-26.
7. Brecht, M –L.; Anglin, M.D. & Dylan, M. 2005. Coerced treatment for methamphetamine abuse: Differential patient characteristics and outcomes. American Journal of Drug and Alcohol Abuse31: 337-56.
8. Brecht, M -L.; Greenwell, L. & Anglin, M.D. 2005. Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system, 1992-2002. Journal ofSubslance Abuse Treatment 29(4): 295-306.
9. Brecht, M.-L.; von Mayrhauser, C.L. & Anglin, M.D. 2000. Methamphetamine and violence: Predictors and relationship to treatment outcomes. Paper presented at the College on Problems of Drug Dependence 2000, 62nd Annual Meeting, June 2000.
10. Broome, K.M.; Rynn, PM. & Simpson, D.D. 1999. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research34: 791-806.
11. California Department of Alcohol and Drug Programs.(CDADP) 2005. Comprehensive Drug Court Implementation Act of /999: Interim Report to the Legislature.Sacramento, CA: CDADP.
12. California Department of Alcohol and Drug Programs (CA ADP). 2004. California Alcohol and Drug Data System (CADDS) Instruction Manual. Accessed at http://www.adp.ca.gov/AOD/manuals/CADDSmanual.pdf
13. Comfort, M.; Sockloff, A.; Loveroo, J. & Kaltenbach, K. 2003. Multiple predictors of substance-abusing women's treatmentandlifeoutcomes: A prospective longitudinal study. Addictive Behaviors28: 199-224.
14. Gerstein, D R. 1994. Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment.Sacramento, CA: California Department of Alcohol and Drug Programs.
15. Gonzales, R. & Rawson, R. 2005. Methamphetamine addiction: Does treatment work?Counselor Magazine6 (5): 16-23. Available online at: www.counselormagazine.com/display_article.asp?aid=oct05methamphetamine.htm
16. Gonzales, R.; Marinelli-Casey, P.; Shoptaw, S.; Ang, A. & Rawson, R. 2006. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment. Journal of Substance Abuse Treatment31: 195-202.
17. Gossop, M.; Marsden, J. & Stewart, D. 2000. Treatment outcomes of stimulant misusers: One year follow-up results from the national treatment outcomes research study (NTORS). Addictive Behaviors25 (4): 509-22.
18. Gossop, M.; Marsden, J.; Stewart, D. & Kidd, T. 2003. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction98 (3): 291-303.
19. Gossop, M.; Marsden, J.; Stewart, D. & Kidd, T. 2002. Changes in use of crack cocaine after drug misuse treatment: 4-5 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence66: 21-8.
20. Gossop, M.; Marsden, J.; Stewart, D. & Rolfe, A. 2000. Patterns of improvement after methadone treatment: I year follow-up results from the National Treatment Outcome Research Study. Drug & Alcohol Dependence60 (3): 275-86.
21. Greenfield, S.; Kolodziej, M.; Sugarman, D.; Muenz, L.; Vagge, L.; He, D. & Weiss, R. 2002. History of abuse and drinking outcomes following inpatient alcohol treatment: A prospective study. Drug and Alcohol Dependence67: 227-34.
22. Grella, C.; Joshi, V. & Hser, Y.-I. 2000. Program variation in treatment outcomes among women in residential treatment. Evaluation Review24: 364-83.
23. Halkitis, P.; Parsons, J. & Stirratt, M. 2001. A double epidemic: Crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality41 (2): 17-35.
24. Harrison, P. & Asche, S. 2001. Out comes monitoring in Minnesota: Treatment implications, practical limitations. Journal of Substance Abuse Treatment 2l:173-83.
25. Hiller, M.; Knight, K.; Broome, K. & Simpson, D. 1998. Legal pressure and treatment retention in a national sample of long-term residential programs. Criminal Justice and Behavior25: 463-81.
26. Hser, Y.-I.; Evans, E. & Huang, Y. 2005. Treatment outcomes among women and men methamphetamine abusers in California. Journal of Substance Abuse Treatment28: 77-85.
27. Hser, Y.-I.; Stark, M.; Paredes, A.; Huang, D.; Anglin, M.D. & Rawson, R. 2006. A 12-year follow-up of a treated cocaine-dependent sample. Journal of Substance Abuse Treatment30: 219-26.
28. Hser, Y.-I.; Evans, E.; Huang, D. & Anglin, M.D. 2004. Relationship between drug treatment services, retention, and outcomes. Psychiatric Services55: 767-74.
29. Hser, Y-I.; Evans, E.; Teruya, C.; Ettner, S.; Hardy, M.; Urada, D.; Huang, Y.-C.; Picazo, R.; Shen, H.; Hsieh, J. & Anglin, M.D. 2003. The California Treatment Outcomes Study (CalTOP), Final Report. Los Angeles. CA: UCLA Integrated Substance Abuse Programs.
30. Hser, Y.-I; Grella, C.; Hsieh, S.-C.; Anglin, M.D. & Brown, B. 1999. Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence57: 137-50.
31. Hubbard, R.; Craddock, S. & Anderson, J. 2003. Overview of 5-year follow-up outcomes in the Drug Abuse Treatment Outcome Studies (DATOS). Journal of Substance Abuse Treatment 25:125-34.
32. lritani, B.J.; Halfors, D.D. & Bauer, D.J. 2007. Crystal methamphetamine use among young adults in the U.S.A. Addiction102: 1102-13.
33. Joe, G.W.; Simpson, D.D. & Broome, K.M. 1999. Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence57: 113-25.
34. Johnston, L.D.; O’Malley, P.M.; Bachman, J.G. & Schulenberg, J.E. 2004. Monitoring the Future National Survey Results on Drug Use, 1975-2003. Volume II: College Students and Adults Ages /9-45 (NIH Publication No. 04-5508). Bethesda. MD: National Institute on Drug Abuse.
35. Kalechstein, A.; Newton, T.F. & Green, M. 2003. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry & Clinical Neuroscience 15(2): 215-20.
36. Kalechstein, A.; Newton, T.F.; Longshore, D.; van Gorp, W.G. & Anglin, M.D. 2000. Psychiatric comorbidity in methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences12: 480-84.
37. King, AC. & Canada, S.A. 2011. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. Journal of Substance Abuse Treatment 26:189-95.
38. Kingree, J.B. 1995. Understanding gender differences in psychosocial functioning and treatment retention. American Journal of Drug and Alcohol Abuse21: 267-81.
39. Latessa, E.J.; Shaffer, D.K. & Lowenkamp, C. 2002. Outcome Evaluation of Ohio's Drug Court Efforts: Final Report. Cincinnati. OH: Center for Criminal Justice Research.
40. Leukefeld, D.; Gallego, M. & Farabee, D. 1997. Drugs. crime. and HIV. Substance Use& Misuse32 (6): 749-56.
41. Ling, W.; Rawson, R. & Shoptaw, S. 2-to Managementof methamphetamine abuse and dependence. Current Psychiatry Reports8: 345-54.
42. Logan, T.; Hoyt, W.; McCollister, K.; French, M.; Leukefeld, C. & Minton, L. 2004. Economic evaluation of drug court: Methodology, results. and policy implications. Evaluation and Program Planning 27(4): 381-96.
43. Longshore, D.; Hawken, A.; Urada, D. & Anglin, M.D. 2006. Evaluation of the Substance Abuse and Crime Prevention Act SACPA Cost-Analysis Report (First and Second Years). Los Angeles, CA: UCLA Integrated Substance Abuse Programs. Available online at: http://www.uclaisap.org/prop36/html/reports.html
44. Longshore, D.; Urada, D.; Evans, E.; Hser, Y-I.; Prendergast, M. & Hawken, A. 2005. Evaluation of the Substance Abuse and Crime Prevention Act: 2004 Report. Los Angeles, CA: UCLA Integrated Substance Abuse Programs. Available online at: http://www.uclaisap. org/prop36/html/reports.html
45. Longshore, D.; Urada, D.; Evans, E.; Hser, Y-I.; Prendergast, M.; Hawken, A.; Bunch, T. & Ettner, S. 2004. Evaluation of the Substance Abuse and Crime Prevention Act: 2003 Report. Los Angeles, CA: UCLA Integrated Substance Abuse Programs. Available online at: http://www.uclaisap.org/prop36/html/reports. html
46. Longshore, D.; Evans, E.; Urada, D.; Teruya, C.; Hardy, M.; Hser, Y-I.; Prendergast, M. & Ettner, S. 2003. Evaluation of the Substance Abuse and Crime Prevention Act: 2002 Report.Los Angeles, CA: UCLA Integrated Substance Abuse Programs. Available online at: http://www.uclaisap.org/prop36/html/reports.html
47. Maglione, M.; Chao, B. & Anglin, D. 2000a. Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs32: 221-28.
48. Maglione, M.; Chao, B. & Anglin, D. 2000b. Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994-1997. Addiction Research8: 65-79.
49. Mansergh, G.; Colfax, G.; Marks, G.; Rader, M.; Guzman, R. & Buchbinder, S. 2001. The Circuit Party Men's Health Survey: Findings and implications for gay and bisexual men. American Journal of Public Health91 (6): 953-58.
50. Marobi, R. 2006. U.S. crackdown sends meth labs south of the border. Los Angeles Times November 26: A1-A12.
51. McCann, U. & Ricaurte, G. 2004. Amphetamine neurotoxicity: Accomplishments and remaining challenges. Neuroscience and Biobehavioral Reviews27: 821-26.
52. McCaul, M.E.; Svikis, D.S. & Moore, R.D. 2001. Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence62: 9-17.
53. McKay, J. & Weiss, R. 2001. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Evaluation Review25 (2): 113-61.
54. McLellan, A.; Alterman, A.; Metzger, D.; Grissom, G.; Woody, G.; Luborsky, L. & O'Brien, C. 1997. Similarity of outcome predictors across opiate, cocaine, and alcohol treatment: Role of treatment services. In: G. Marlatt & G. Van den Bos (Eds.)Addictive Behaviors: Readings on Etiology, Prevention, and Treatment.Washington, DC: American Psychological Association.
55. Mertens, J.R. & Weisner, C M. 2000. Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research24: 1525-33.
56. National Drug Intelligence Center. 2006 National Drug Threat Assessment. Washington, D.C.: U. S. Department of Justice. Available online at www.usdoj.gov/ndic/pubs111 18862/index.htm
57. National Narcotics Intelligence Consumers Committee. 1997. The Supply of Illicit Drugs to the United States.Washington, DC: Drug Enforcement Administration.
58. Newton, T; Roache, J.; De La Garza, R.; Fong, T.; Wallace, C.; Li, SH.; Elkashef, A.; Chiang, N. & Kahn, R. 2006. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology31: 1537-44.
59. Nordahl, T.; Salo, R. & Leamon, N. 2003. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. Journal of Neuropsychiatry and Clinical Neuroscience15 (3): 317-25.
60. Office of the National Drug Control Policy (ONDCP). 2002. Pulse Check: Trends in Drug Abuse January-June 2002.Washington, DC: The White House.
61. Prendergast, M.; Podus, D. & Chang, E. 2000. Program factors and treatment outcomes in drug dependence treatment: An examination using meta-analysis. Substance Use and Misuse35 (12-14): 1931-65.
62. Prendergast, M.; Podus, D. & McCormack, K. 1998. Bibliography of literature reviews on drug abuse treatment effectiveness. Journal of Substance Abuse Treatment 15(3): 267-70.
63. Prendergast, M.; Podus, D.; Chang, E. & Urada, D. 2002. The effectiveness of drug abuse treatment: A meta-analysis of comparison group studies. Drug and Alcohol Dependence67: 53-72.
64. Rawson, R.; Gonzales, R.; & Brethen, P. 2002.Treatmentofmethamphetamine use disorders: An update. Journal of Substance Abuse Treatment23: 145-50.
65. Rawson, R.; Marinelli-Casey, P.; Anglin, M.D.; Dickow, A.; Frazier, Y.; Gallagher, C.; Galloway, G.P; Herrell, J.; Huber, A.; McCann, M.J.; Obert, J.; Pennell, S.; Reiber, C.; Vandersloot, D. & Zweben, J. 2004. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction99 (6): 708-17.
66. Rawson, R.; Huber, A.; Brethen, P.; Obert, J.; Gulati, V.; Shoptaw, S. & Ling, W. 2002. Status of methamphetamine users 2-5 years after outpatient treatment. Journal of Addictive Diseases21: 107-19.
67. Rempel, M. 2003. The New York State Adult Drug Court Evaluation: Policies, Participants and Impacts.New York, NY: Center for Court Innovation.
68. Roll, J.; Petry, N.; Stitzer, M; Brecht, M.-L.; Peirce, J.; McCann, M.; Blaine, J.; MacDonald, M.; DiMaria, J.; Lucero, L. & Kellogg, S. 2006. Contingency management for the treatment of methamphetamine use disorders. American Journal of Psychiatry163 (2): 1993-99.
69. Rutkowski, B. 2006. California Substance Abuse Research Consortium. September 2005: Update on recent methamphetamine trends in four California regions. Journal ofP.svchoactive Drugs SARC Supplement 3: 369-75.
70. Schildhaus, S.; Gerstein, D.; Dugoni, B., Brittingham, A. & Cerbone, F 2000. Services research outcomes study: Explanation of treatment effectiveness. using individual-level and programmatic variables. Substance Use and Misuse35: 1879-1910.
71. Shoptaw, S.; Peck, J.; Reback, C. & Rotheram-Fuller, E. 2003. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. Journal of Psychoactive Drugs35 (Supplement 1): 161-8.
72. Simon, S.; Berman, S.; Dacey, J.; Ling, W.; Rawson, R. & London, E. 2004. Logical reasoning in methamphetamine abusers during the first month of abstinence. Paper presented at the College on Problems of Drug Dependence. 66th Annual Meeting. June 2004.
73. Simpson, D.; Joe, G.; Fletcher, B.; Hubbard, R. & Anglin, M.D. 1999. A national evaluation of treatment outcomes for cocaine dependence. Archive s of General Psychiatry56: 507-14.
74. Smith, L.; LaGasse, L.; Derauf, C.; Grant, P; Shah, R.; Arria, A.; Huestis, M.; Haning, W.; Strauss, A.; Grotta, S.; Liu, J. & Lester, B. 2006. The infant development, environment, and lifestyle study: Effects of prenatal methamphetamine exposure, polydrug exposure. and poverty on intrauterine growth. Pediatrics118 (3): 1149-56.
75. Smith, L.; Yonekura, M; Wallace, T.; Berman, N.; Kuo, J. & Berkowitz, C. 2003. Effects of prenatal methamphetamine exposure onfetal growth and drug withdrawal symptoms in infants born at term. Developmental ami Behavioral Pediatrics24: 17-23.
76. Stewart, J. & Meeker, J. 1997. Fetal and infant deaths associated with maternal methamphetamine abuse. Journal ofAnalytical Toxicology21:515-17.
77. Strauss, S.M. & Falkin, G.P 2000. The relationship between the quality of drug user treatment and program completion: Understanding the perceptions of women in a prison-based program. Substance Use& Misuse 35: 2127-59.
78. Substance Abuse and Mental Health Services Administration (SAMHSA). 2006. Treatment Episode Data Set (TEDS). Highlight.s-2005. National Admissions to Substance Abuse Treatment Services. DASIS Series S-36, DHHS Publication No. (SMA) 07-4229. Rockville. MD: Office of Applied Studies.
79. Substance Abuse andMental Health ServicesAdministration (SAMHSA). 2005a. Result s from the 2(X)4 National Survey on Drug Use and Health: National Findings. NSDUH Series H-28. DHHS Publication No. (SMA) 05-4062. Rockville, MD: Office of Applied Studies.
80. Substance Abuse and Mental Health Services Administration (SAMHSA). 2005b. The NSDUH Report-Methamphetamine Use, Abu se, and Dependence: 2002, 2003, and 2004.Rockville MD: Office of Applied Studies.
81. Substance Abuse and Mental Health Services Administration (SAMHSA). 2002. Treatment Episode Data Set (TEDS): /992-2000. National Admissions to Substance Abuse Treatment Services. DASIS Series S-17, DHHS Publication No. (SMA) 02-3727. Rockville. MD: Office of Applied Studies.
82. Swellow, K. 2003. Children at clandestine methamphetamine labs: Helping meth's youngest victims. OVC Bulletin, June. Available online at: www.ojp.usdoj.gov/ovc/publications/bulletins/children/l97590.pdf
83. Thiede, H.; Valleroy, L.A.; MacKellar, D.A.; Celentano, D.; Ford, W.L.; Hagan, H.; Koblin, B.A.; LaLota, M.; McFarland, W.; Shehan, D.A. & Torian, L.V. 2003. Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. American JournalofPublic Health39 (2): 1915-21.
84. Travis, J. & Vareen, D. 2000. Final Report, Methamphetamine Interagency Task Force. Washington, DC: National Institute of Justice. Available online at http://www.ncjrs.org/pdffiles1/nij/l80155.pdf
85. Volkow, N.D.; Chang, L.; Wang, G.-J.; Fowler, J.S.; Leonido-Yee, M.; Franceschi, D.; Sedler, M.J.; Gatley, S.J.; Hitzemann, R.; Ding, Y-S.; Logan, J.; Wong, C. & Miller, E.N. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry158 (32): 377-82.
86. Wright, D. & Sathe, N. 2006. State Estimates of Substance Use from the 2(X)3-2(X)04 National Survey on Drug Use and Health (DHHS Publication No. SMA 06-4142. NSDUH Series H-29). Rockville. MD: Substance Abuse and Mental Health Services Administration. Office of Applied Studies.
87. 9 One-year outcomes of treated and untreated alcohol-dependent individuals. Addiction98: 901-11.
88. 9 Treatment duration and improvement in drug use. Addiction98: 673-84.